November/December 2014




As Treatment Options Expand, Researchers Continue to Explore the Basis of MS

New treatments have emerged and others are expected. What have changes meant for patient care?

A Q&A with Moses Rodriguez, MD

In Epilepsy Care, Non-pharmacologic Research Takes Center Stage

Researchers say minimally invasive surgeries, alternative interventions, and new genetic findings are the top stories of 2014.

A Q&A with Lara Jehi, MD and Evelyn S. Tecoma MD, PhD

Stroke Research Continues to Support Rapid Assessment, Personalized Treatment Approaches

Several key studies were published this year, and results of a stem cell study may be on the horizon.

With Pooja Khatri, MD and M. Shazam Hussain, MD

Ongoing Evolution: Understanding Concussion’s Effects

Researchers are focused on better detection and outcomes from brain injury.

A Q&A with Tad Seifert, MD, Laura J. Balcer, MD, MSCE and Steven L. Galetta, MD

Global Outcomes Data and Possible New Therapies in the Huntington’s Pipeline

Researchers are focused on patient outcomes on a global scale and join clinicians in the vigil for new drug approvals.

A Q&A with George Yohrling, PhD and Ed Wild, PhD

Innovation Becomes the Leading Principle in Pain

For integrative care, better outcomes, and lower costs, clinicians need to think outside the box, a specialist says.

By Michael Ashburn, MD, MPH

The Disappearing Story: Recapping Sleep Research

The biggest news in sleep this year may have been the story that wasn’t

A Q&A with Erik K. St. Louis, MD and Carl Bazil, MD, PhD

Biomarkers Setting the Pace of Alzheimer’s Research

Clinicians and researchers must determine how to best use emerging data, such as information on biomarkers.

A Q&A with John Trojanowski, MD, PhD and Russell H. Swerdlow, MD

ALS: Demystifying the Role of Genetics in Pathogenesis, Treatment

The ice bucket challenge may have been this year’s ALS headline story, but research is progressing on gene research.

With Cynthia Bodkin, MD


Headache Medicine: A Crossroad of Otolaryngology, Ophthalmology, and Neurology

Numerous symptoms can suggest both ophthalmological and neurological disorders.

By Paul G. Mathew, MD, FAHS

First CMS Attempt at Transparency Is Remarkably Cloudy

A search for clarity in the initial Open Payments experience.

By Steven J. Cagnetta, Esq, and Steven K. Ladd


The Most Important Element of Your Financial Plan: Why Flexibility is Crucial to Meeting Long Term Goals, Part I

Flexibility may be the most important factor in a sophisticated long term plan.

By David B. Mandell, JD, MBA and Jason M. O’Dell, MS, CWM

In The Pipeline: Don’t Bother: Investigational Compound Reduces AD-related Agitation

Alzheimer’s patients who experience agitation saw a nearly 50 percent decline in their symptoms after treatment with an investigational therapy.

By Zac Haughn, Senior Associate Editor

Monomelic Amyotrophy (Hirayama’s Disease)

Last month’s case presented weakness and atrophy of the right hand muscles in a 47-year-old man.

By Azis Shaibani, MD, FACP, FAAN

Novel Ideas Dot Future of Headache Care

Two specialists share their thoughts on the year that was in headache care, as well as three novel delivery systems to look for in the future.

A Q&A with David Dodick, MD and Paul G. Mathew, MD, FAHS

Contact Info

For advertising rates and opportunities:
Steve Farrell

For further information:
Alan Guralnick
Group Publisher
(484) 581-1832

About Practical Neurology

Launched in January 2002, Practical Neurology strives to enhance quality of care and improve the daily operation of neurology practices. Each month, our experts explain the real-world significance of recent advances in neurologic science and offer step-by-step advice on how to overcome the clinical and business challenges neurologists face. Our straightforward, how-to articles give neurologists tools they can put into practice right away.

Website Design by Sides Media